NEA 17 GP, LLC
SEC-identified person · CIK 1796821 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Korro Bio, Inc. KRRO | Officer | filed 2023 - 2026 |
| Spyglass Pharma, Inc. SPG | Officer | filed 2026 - 2026 |
| Neuehealth, Inc. NEUE | Director | filed 2022 - 2025 |
| MBX Biosciences, Inc. MBX | Officer | filed 2024 - 2024 |
| Savara Inc [ANX] | Officer | filed 2021 - 2023 |
| Robinhood Markets, Inc. HOOD | Director | filed 2021 - 2022 |
| Monte Rosa Therapeutics, Inc. GLUE | Officer | filed 2021 - 2021 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.